Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | flap structure-specific endonuclease 1 | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | sphingomyelin phosphodiesterase 1, acid lysosomal | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Trypanosoma brucei | exonuclease, putative | flap structure-specific endonuclease 1 | 380 aa | 322 aa | 24.5 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0019 | 0.1356 | 0.1356 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.5765 | 1 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0019 | 0.1356 | 0.2352 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.1356 | 0.3641 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.5765 | 0.5765 |
Toxoplasma gondii | flap structure-specific endonuclease 1, putative | 0.0031 | 0.2684 | 1 |
Trichomonas vaginalis | flap endonuclease-1, putative | 0.0031 | 0.2684 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.3724 | 1 |
Echinococcus granulosus | GPCR family 2 | 0.0019 | 0.1356 | 0.5051 |
Schistosoma mansoni | flap endonuclease-1 | 0.0028 | 0.2361 | 0.6339 |
Entamoeba histolytica | Acid sphingomyelinase-like phosphodiesterase, putative | 0.01 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.1356 | 0.3641 |
Loa Loa (eye worm) | hypothetical protein | 0.01 | 1 | 1 |
Echinococcus granulosus | flap endonuclease 1 | 0.0031 | 0.2684 | 1 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.1356 | 0.5051 |
Giardia lamblia | Flap structure-specific endonuclease | 0.0031 | 0.2684 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.3724 | 0.646 |
Trypanosoma brucei | flap endonuclease-1 (FEN-1), putative | 0.0031 | 0.2684 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.1356 | 0.3641 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0019 | 0.1356 | 0.2352 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.1356 | 0.3641 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.1356 | 0.5051 |
Brugia malayi | Flap endonuclease-1 | 0.0031 | 0.2684 | 0.4657 |
Echinococcus multilocularis | GPCR, family 2 | 0.0019 | 0.1356 | 0.5051 |
Trypanosoma cruzi | flap endonuclease-1 (FEN-1), putative | 0.0031 | 0.2684 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.1356 | 0.1356 |
Echinococcus multilocularis | flap endonuclease 1 | 0.0031 | 0.2684 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.5765 | 0.5765 |
Plasmodium falciparum | flap endonuclease 1 | 0.0031 | 0.2684 | 1 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.1356 | 0.5051 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.1356 | 0.5051 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.3724 | 0.3724 |
Leishmania major | flap endonuclease-1 (FEN-1), putative | 0.0031 | 0.2684 | 1 |
Loa Loa (eye worm) | flap endonuclease-1 | 0.0031 | 0.2684 | 0.2684 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.5765 | 1 |
Plasmodium vivax | flap endonuclease 1, putative | 0.0031 | 0.2684 | 1 |
Entamoeba histolytica | Flap nuclease, putative | 0.0031 | 0.2684 | 0.2684 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | > 79.37 um | PUBCHEM_BIOASSAY: TR-FRET dose response biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPAR gamma): non-selective agonists. (Class of assay: confirmatory) [Related pubchem assays: 1297, 1032 ] | ChEMBL. | No reference |
EC50 (functional) | > 79.37 um | PUBCHEM_BIOASSAY: TR-FRET dose response biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPAR gamma): non-selective agonists. (Class of assay: confirmatory) [Related pubchem assays: 1301 (Confirmation screen.), 1048 (Primary screen.)] | ChEMBL. | No reference |
EC50 (binding) | > 79.37 uM | PUBCHEM_BIOASSAY: TR-FRET dose response biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPAR gamma): non-selective agonists. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1300, AID1808, AID504735, AID631] | ChEMBL. | No reference |
Potency (functional) | 0.0033 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 2.2387 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813] | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 19.9526 uM | PubChem BioAssay. Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ] | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 1467, 2100, 2112, 1473, 1466 ] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | ||
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.